Accellient Partners
Biotechnology, 1000 Winter St, Waltham, Massachusetts, 02451, United States, 1-10 Employees
Phone Number: +17*********
Who is ACCELLIENT PARTNERS
Accellient Partners is a fully integrated and dedicated team of drug development experts with broad drug development, regulatory and scientific experience. Our team designs, implements an...
Read More
- Headquarters: 1000 Winter St, Waltham, Massachusetts, 02451, United States
- Date Founded: 2010
- Employees: 1-10
- Revenue: $1 Million to $5 Million
- Active Tech Stack: See technologies
- CEO: Bill Kerns
Industry: Biotechnology
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from ACCELLIENT PARTNERS
Accellient Partners Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Accellient Partners
Answer: Accellient Partners's headquarters are located at 1000 Winter St, Waltham, Massachusetts, 02451, United States
Answer: Accellient Partners's phone number is +17*********
Answer: Accellient Partners's official website is https://accellient.com
Answer: Accellient Partners's revenue is $1 Million to $5 Million
Answer: Accellient Partners's SIC: 2834
Answer: Accellient Partners has 1-10 employees
Answer: Accellient Partners is in Biotechnology
Answer: Accellient Partners contact info: Phone number: +17********* Website: https://accellient.com
Answer: Accellient Partners is a fully integrated and dedicated team of drug development experts with broad drug development, regulatory and scientific experience. Our team designs, implements and manages all product development needs for biotech co's. Accellients development model leverages know-how, technology and business experience to; Minimize program risks and lower costs; Accelerate development timelines via tailored development plans; Achieve targeted milestones to improve return on investment; and Assist in the capital raising process. We develop and manage programs from late discovery through IND submission and Phase 2. We also continue to support the manufacturing requirements and nonclinical development needs of projects through the complex registration process. Our approach enables business leaders and investors to fully assess all risk factors and their impact on success to support major investment and infrastructure decisions. Accellient partners with clients in all markets. We provide core technical drug development expertise and an extensive network of expert affiliates, KOL's and proven service providers that complement your discovery, development and management team. We are currently filing electronic INDs quarterly and have significant experience working with all divisions of the FDA. Accellient offers an efficient and cost effective approach and strives to be the biopharmaceutical and investment industries virtual drug development partner of choice.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month